Go Back

Panda Perspectives

Delivering candid conversations with influential healthcare leaders, offering a look at the strategies, challenges, and passions that are driving meaningful change in the industry.

Panda Perspectives

David Clayton

MarketScale
December 17, 2024

In this Panda Perspectives episode, Duke Health’s David Claxton shares insights on measuring digital health ROI, drawing from his experience in both health systems and as a former digital health vendor. He discusses challenges in validating ROI claims, the importance of realistic vendor partnerships, and the surprising under-prioritization of clinic time savings. David highlights Duke’s AI-driven efforts to improve provider workflows, reduce burnout, and enhance patient care, emphasizing the need for trust, collaboration, and tangible outcomes in digital health adoption.

Recent Episodes

The Value of a Restoration Team with Healthcare Experience
View episode

The Value of a Restoration Team with Healthcare Experience

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

CensisAI²
View episode

Inside the SPD Revolution: Robby Miller on Embracing CensisAI²

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

resistance
View episode

Inside Oncology Drug Development: Overcoming Resistance with Science

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Launch Your Branded Show Today

Engage your audience with original, industry-specific content.

Book a Demo Talk to an Expert